Adalimumab for Nail Psoriasis: Efficacy and Safety from the Open-Label Extension of a Phase-3, Randomized, Placebo-Controlled Trial. J of Skin [Internet]. 2017 Oct. 27 [cited 2025 Jun. 25];1(3.1):s97. Available from: https://skin.dermsquared.com/skin/article/view/75